<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7319607\results\search\disease\results.xml">
  <result pre="Elsevier Ltd. pmcid: 7319607S0306-9877(20)31200-7 doi: 10.1016/j.mehy.2020.110027110027 : Article Why the" exact="lower" post="reported prevalence of asthma in patients diagnosed with COVID-19"/>
  <result pre="doi: 10.1016/j.mehy.2020.110027110027 : Article Why the lower reported prevalence of" exact="asthma" post="in patients diagnosed with COVID-19 validates repurposing EDTA solutions"/>
  <result pre="validates repurposing EDTA solutions to prevent and manage treat COVID-19" exact="disease" post="CashmanDaniel P.dan94022@gmail.com[], pmc-release: 2020-6-6ppub: 2020-11epub: 2020-6-6144110027110027received: 2020-5-8rev-recd: 2020-6-11accepted: 2020-6-20(C)"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="drug or a vaccine for SARS-CoV-2/COVID-19 infections; now exceeding 10,300,000" exact="infections" post="worldwide. In the absence of animal models to test"/>
  <result pre="for SARS-CoV-2/COVID-19 infections; now exceeding 10,300,000 infections worldwide. In the" exact="absence of" post="animal models to test drugs, we need to find"/>
  <result pre="in clinical data, especially the recent reports describing an unexpected" exact="asthma" post="paradox. Asthma is considered a high medical risk factor"/>
  <result pre="data, especially the recent reports describing an unexpected asthma paradox." exact="Asthma" post="is considered a high medical risk factor for susceptibility"/>
  <result pre="paradox. Asthma is considered a high medical risk factor for" exact="susceptibility to" post="SARS-CoV-2/COVID-19 infection, yet asthma is not on the list"/>
  <result pre="high medical risk factor for susceptibility to SARS-CoV-2/COVID-19 infection, yet" exact="asthma" post="is not on the list of top 10 chronic"/>
  <result pre="yet asthma is not on the list of top 10" exact="chronic" post="health problems suffered by people who died from SARS-CoV-2/COVID-19."/>
  <result pre="this paradox requires looking beyond the binary model of a" exact="viral" post="receptor-binding domain (RBD) attaching to the ACE-2 receptor. A"/>
  <result pre="almost identical to those that were recently discovered SARS-CoV-1. These" exact="viral" post="calcium-dependent binding domains can facilitate membrane fusion only after"/>
  <result pre="of EDTA excipients in nebulized Î²2-agonist medicines can disrupt SARS-CoV-2/COVID-19" exact="infection" post="and can explain the asthma paradox. This model validates"/>
  <result pre="Î²2-agonist medicines can disrupt SARS-CoV-2/COVID-19 infection and can explain the" exact="asthma" post="paradox. This model validates repurposing EDTA in nebulizer solutions"/>
  <result pre="active drug for treating COVID-19 infections. Repurposed EDTA delivery to" exact="respiratory" post="tissues at an initial target dose of 2.4Â mg"/>
  <result pre="for SARS-CoV-2/COVID-19 in consideration of the new calcium requirements for" exact="virus infection" post="and the regular presence of EDTA excipients in common"/>
  <result pre="SARS-CoV-2/COVID-19 in consideration of the new calcium requirements for virus" exact="infection" post="and the regular presence of EDTA excipients in common"/>
  <result pre="infection and the regular presence of EDTA excipients in common" exact="asthma" post="medications such as Metaproterenol. Finally, the natural history of"/>
  <result pre="receptors, the Coronavirus viruses enter cells through endocytosis with the" exact="viral" post="spike proteins driving the fusion of viral and endosomal"/>
  <result pre="endocytosis with the viral spike proteins driving the fusion of" exact="viral" post="and endosomal membranes to enable insertion of the viral"/>
  <result pre="of viral and endosomal membranes to enable insertion of the" exact="viral" post="genome into the cytoplasm [2]. The less pathogenic Alphacorona"/>
  <result pre="[3], [4]. HCoV-229E is highly prevalent and most people experience" exact="acute" post="infection during their childhood [5]. One study found 65%"/>
  <result pre="[4]. HCoV-229E is highly prevalent and most people experience acute" exact="infection" post="during their childhood [5]. One study found 65% of"/>
  <result pre="highly prevalent and most people experience acute infection during their" exact="childhood" post="[5]. One study found 65% of the children between"/>
  <result pre="Spike (S) protein is 1273 amino acid long and S" exact="viral" post="envelope protein that has two main subunits (S1 and"/>
  <result pre="present within the S2 subunit discussed below. In SARS-CoV-2/COVID-19 the" exact="type II" post="transmembrane serine protease (TTSP) TMPRSS2 cleaves the S1â€&quot;S2 subunits"/>
  <result pre="serve as substrate recognition sites. Calcium-dependent fusion process required for" exact="viral infection" post="Even now, the actual mechanism ofÂ virus membrane fusionÂ"/>
  <result pre="as substrate recognition sites. Calcium-dependent fusion process required for viral" exact="infection" post="Even now, the actual mechanism ofÂ virus membrane fusionÂ"/>
  <result pre="membrane fusion (via the S2 domain containing the fusion peptide)." exact="Viral" post="entry into host cells requires that there is a"/>
  <result pre="fusion loop. These fusion peptides (fusion loops, FL) are generally" exact="external" post="amino acid domains that insert into the host membranes"/>
  <result pre="recently discovered for Rubella [16] and later described for SARS-CoV-1" exact="infection" post="[17]. While two fusion peptides (FLs) were found with"/>
  <result pre="lethality of the beta CoVs and the apparent resistance of" exact="asthma" post="patients to SARS-CoV-2 infection due to inhaling medications containing"/>
  <result pre="CoVs and the apparent resistance of asthma patients to SARS-CoV-2" exact="infection" post="due to inhaling medications containing EDTA excipients. Strategy for"/>
  <result pre="be given routinely for the treatment of COVID-19. Accordingly, the" exact="asthma" post="paradox is unlikely due to steroid treatments becauseÂ recent"/>
  <result pre="for the treatment of COVID-19 and prior reports indicate that" exact="systemic" post="steroids for treating SARS-CoV-1 may have been harmful [21]."/>
  <result pre="preservative or stabilizing agents in nebulizer solutions used to treat" exact="asthma" post="and chronic obstructive pulmonary disease [23]. Historically, common nebulizer"/>
  <result pre="stabilizing agents in nebulizer solutions used to treat asthma and" exact="chronic" post="obstructive pulmonary disease [23]. Historically, common nebulizer therapies used"/>
  <result pre="in nebulizer solutions used to treat asthma and chronic obstructive" exact="pulmonary" post="disease [23]. Historically, common nebulizer therapies used by asthma"/>
  <result pre="nebulizer solutions used to treat asthma and chronic obstructive pulmonary" exact="disease" post="[23]. Historically, common nebulizer therapies used by asthma and"/>
  <result pre="obstructive pulmonary disease [23]. Historically, common nebulizer therapies used by" exact="asthma" post="and COPD patients have had concentrations of EDTA available"/>
  <result pre="Medical hypothesis Recent medical articles indicate that there isÂ markedly" exact="lower" post="reported prevalence of asthma and COPD in patients diagnosed"/>
  <result pre="articles indicate that there isÂ markedly lower reported prevalence of" exact="asthma" post="and COPD in patients diagnosed with COVID-19 [33], [34]."/>
  <result pre="with COVID-19 [33], [34]. To explain the unexpected observation that" exact="asthma" post="patients and chronic obstructive pulmonary disease patients appear resistant"/>
  <result pre="[34]. To explain the unexpected observation that asthma patients and" exact="chronic" post="obstructive pulmonary disease patients appear resistant to COVID-19, it"/>
  <result pre="explain the unexpected observation that asthma patients and chronic obstructive" exact="pulmonary" post="disease patients appear resistant to COVID-19, it is postulated"/>
  <result pre="the unexpected observation that asthma patients and chronic obstructive pulmonary" exact="disease" post="patients appear resistant to COVID-19, it is postulated that;"/>
  <result pre="the SARS-CoV-2 (COVID-19) spike protein (i.e., the ligand), 3)SARS-CoV-2 (COVID-19)" exact="infection" post="is, and has been disrupted by exposure to calcium"/>
  <result pre="chelating agents such as EDTA in nebulizer medications inhaled by" exact="asthma" post="patients to either directly interrupt the cleavage of the"/>
  <result pre="2 (FL2Â =Â Amino Acids 835â€&quot;855) was conducted using the" exact="Protein" post="Blast program from the National Center for Biotechnology Information"/>
  <result pre="Table 1 and Table 2 exhibit the data from the" exact="Protein" post="Blast Alignment Tool data from the calcium binding fusion"/>
  <result pre="regions for SARS-CoV-1 described in 2017. Additionally, the less pathogenic" exact="Alpha" post="coronavirus 229E (HCoV-229E) has a solitary FL2 domain and"/>
  <result pre="Additionally, the less pathogenic Alpha coronavirus 229E (HCoV-229E) has a" exact="solitary" post="FL2 domain and a reduced homology length compared to"/>
  <result pre="vaccine that would be able to generate host immunity, yet" exact="lower" post="the pathogenicity to level of HCoV-229E. Testing of the"/>
  <result pre="be used to directly demonstrate that EDTA can inhibit SARS-CoV-2" exact="infection" post="with relative safety based on prior studies of asthmatics"/>
  <result pre="HCoV-229E was discovered in 1966 and is a less pathogenic" exact="Alpha" post="coronavirus that appears to have crossed species barriers to"/>
  <result pre="in animals was 750Â mg/kg/day [41]. Conclusion Searching for the" exact="viral" post="mechanisms to elucidate why asthma patients appear resistant to"/>
  <result pre="[41]. Conclusion Searching for the viral mechanisms to elucidate why" exact="asthma" post="patients appear resistant to COVID-19 infection uncovered evidence for"/>
  <result pre="mechanisms to elucidate why asthma patients appear resistant to COVID-19" exact="infection" post="uncovered evidence for the key role of calcium in"/>
  <result pre="that utilize calcium. Analysis of nebulizer solutions typically used by" exact="asthma" post="patients, for example Metaproterenol, revealed the presence of an"/>
  <result pre="it can still disrupt 2 key steps in the SARS-CoV-2/COVID-19" exact="infectious" post="process. Accordingly, repurposing EDTA from excipient to therapeutic nebulized"/>
  <result pre="to utilize EDTA to both reduce COVID-19 transmission and treat" exact="infection" post="through relatively safe modalities that include nebulizer or mechanical"/>
  <result pre="facemask under direct medical supervision, and if tolerated, the more" exact="stable" post="patients may be treated at home or as outpatient"/>
  <result pre="clinically-proven protease inhibitorCell2020 3HamreD.ProcknowJ.J.A new virus isolated from the human" exact="respiratory" post="tractProc Soc Exp Biol Med12111966 Jan1901934285768 4AlmeidaJ.D.TyrrellD.A.The morphology of"/>
  <result pre="the human respiratory tractProc Soc Exp Biol Med12111966 Jan1901934285768 4AlmeidaJ.D.TyrrellD.A.The" exact="morphology" post="of three previously uncharacterized human respiratory viruses that grow"/>
  <result pre="Biol Med12111966 Jan1901934285768 4AlmeidaJ.D.TyrrellD.A.The morphology of three previously uncharacterized human" exact="respiratory" post="viruses that grow in organ cultureJ Gen Virol1219671751784293939 5ShiratoK.KawaseM.WatanabeO.HirokawaC.MatsuyamaS.NishimuraH.Differences"/>
  <result pre="SRCR fold. Life Sci Alliance. 2020;3(4). 16DubÃ©M.ReyF.A.KielianM.Rubella virus: first calcium-requiring" exact="viral" post="fusion proteinPLoS Pathog10201412 17LaiA.L.MilletJ.K.DanielS.FreedJ.H.WhittakerG.R.The SARS-CoV fusion peptide forms an"/>
  <result pre="20MorraM.E.Van ThanhL.KamelM.G.Clinical outcomes of current medical approaches for Middle East" exact="respiratory" post="syndrome: a systematic review and meta-analysisRev Med Virol2832018e1977 21RussellC.D.MillarJ.E.BaillieJ.K.Clinical"/>
  <result pre="peripheryJ Appl Physiol71519911848185510.1152/jappl.1991.71.5.18481662197 29LamasG.A.GoertzC.BoineauR.Effect of disodium EDTA chelation regimen on" exact="cardiovascular" post="events in patients with previous myocardial infarction: the TACT"/>
  <result pre="Wyse DG, Galbraith PD. et al. Chelation therapyÂ forÂ ischemic" exact="heart" post="disease: aÂ randomized controlled trial. JAMA. 2002;287(4):481â€&quot;6. 33Halpin DMG,"/>
  <result pre="DMG, Faner R, Sibila O, Badia JR, Agusti A. Do" exact="chronic" post="respiratory diseases or their treatment affect the risk of"/>
  <result pre="Faner R, Sibila O, Badia JR, Agusti A. Do chronic" exact="respiratory" post="diseases or their treatment affect the risk of SARS-CoV-2"/>
  <result pre="Res.Â 2013;41 (Web Server issue):W29-33. 36FungS.Y.YuenK.S.YeZ.W.ChanC.P.JinD.Y.A tug-of war between severe" exact="acute" post="respiratory syndrome coronavirus 2 and host antiviral defense: lessons"/>
  <result pre="2013;41 (Web Server issue):W29-33. 36FungS.Y.YuenK.S.YeZ.W.ChanC.P.JinD.Y.A tug-of war between severe acute" exact="respiratory" post="syndrome coronavirus 2 and host antiviral defense: lessons from"/>
  <result pre="(Web Server issue):W29-33. 36FungS.Y.YuenK.S.YeZ.W.ChanC.P.JinD.Y.A tug-of war between severe acute respiratory" exact="syndrome" post="coronavirus 2 and host antiviral defense: lessons from other"/>
  <result pre="39CallowK.A.ParryH.F.SergeantM.TyrrellD.A.J.The time course of the immune response to experimental coronavirus" exact="infection" post="of manEpidemiol Infect1052199043544610.1017/S09502688000480192170159 40U.S. Considering COVID-19 Immunity Cards: What"/>
 </snippets>
</snippetsTree>
